167 related articles for article (PubMed ID: 15075383)
1. Imidazoline receptors but not alpha 2-adrenoceptors are regulated in spontaneously hypertensive rat heart by chronic moxonidine treatment.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
J Pharmacol Exp Ther; 2004 Aug; 310(2):446-51. PubMed ID: 15075383
[TBL] [Abstract][Full Text] [Related]
2. Testing conception of engagement of imidazoline receptors in imidazoline drugs effects on isolated rat heart atria.
Radwanska A; Dlugokecka J; Wasilewski R; Kaliszan R
J Physiol Pharmacol; 2009 Mar; 60(1):131-42. PubMed ID: 19439815
[TBL] [Abstract][Full Text] [Related]
3. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.
Olmos G; Miralles A; Barturen F; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1000-7. PubMed ID: 1545372
[TBL] [Abstract][Full Text] [Related]
4. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
[TBL] [Abstract][Full Text] [Related]
5. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
[TBL] [Abstract][Full Text] [Related]
6. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
[TBL] [Abstract][Full Text] [Related]
7. The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X.
Velliquette RA; Ernsberger P
J Pharmacol Exp Ther; 2003 Aug; 306(2):646-57. PubMed ID: 12756274
[TBL] [Abstract][Full Text] [Related]
8. Normalization of up-regulated cardiac imidazoline I(1)-receptors and natriuretic peptides by chronic treatment with moxonidine in spontaneously hypertensive rats.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
Ann N Y Acad Sci; 2003 Dec; 1009():274-8. PubMed ID: 15028599
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
[TBL] [Abstract][Full Text] [Related]
10. Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides.
Mukaddam-Daher S; Gutkowska J
Braz J Med Biol Res; 2004 Aug; 37(8):1239-45. PubMed ID: 15273826
[TBL] [Abstract][Full Text] [Related]
11. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
12. Moxonidine: a new antiadrenergic antihypertensive agent.
Prichard BN; Graham BR; Owens CW
J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
[TBL] [Abstract][Full Text] [Related]
13. Affinity constants and beta-adrenoceptor reserves for isoprenaline on cardiac tissue from normotensive and hypertensive rats.
Doggrell SA; Petcu EB; Barnett CW
J Pharm Pharmacol; 1998 Feb; 50(2):215-23. PubMed ID: 9530991
[TBL] [Abstract][Full Text] [Related]
14. Biphasic dose-dependent modulation of cardiac parasympathetic activity by moxonidine, an imidazoline I1-receptor agonist.
Turcani M
J Cardiovasc Pharmacol; 2008 Dec; 52(6):524-35. PubMed ID: 19034032
[TBL] [Abstract][Full Text] [Related]
15. Imidazoline receptors in the heart: characterization, distribution, and regulation.
El-Ayoubi R; Gutkowska J; Regunathan S; Mukaddam-Daher S
J Cardiovasc Pharmacol; 2002 Jun; 39(6):875-83. PubMed ID: 12021582
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
Piletz JE; Zhu H; Chikkala DN
J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
[TBL] [Abstract][Full Text] [Related]
17. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
Moreira TS; Takakura AC; Menani JV; Colombari E
Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
[TBL] [Abstract][Full Text] [Related]
18. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
[TBL] [Abstract][Full Text] [Related]
19. Renal alpha 2a/d-adrenoceptor subtype function: Wistar as compared to spontaneously hypertensive rats.
Intengan HD; Smyth DD
Br J Pharmacol; 1997 Jul; 121(5):861-6. PubMed ID: 9222541
[TBL] [Abstract][Full Text] [Related]
20. Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Ribas C; Miralles A; García-Sevilla JA
Br J Pharmacol; 1993 Sep; 110(1):99-106. PubMed ID: 8106111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
